医药品·生物科技的资产收购交易 (2016～2024年)

本报告提供全球医药品·生物科技的各种资产 (事业资产，产品资产，特许权资产，技术资产) 的收购交易的缔结状况相关分析，彙整整体交易数量·交易额的转变和预测 (2016～2024年)，近几年的代表性交易案例，主要企业的交易缔结动向，各技术·各治疗领域达成交易的动向等资讯，为您概述为以下内容。

目录

摘要整理

第1章 简介

第2章 资产收购交易趋势

• 简介
• 资产收购交易定义
• 资产收购交易趋势 (2016年以后)
  • 资产收购交易趋势:各年度 (2016～2024年)
  • 资产收购交易趋势:各开发阶段 (2016～2024年)
  • 资产收购交易趋势:各产业领域 (2016～2024年)
  • 资产收购交易趋势:各治疗领域 (2016～2024年)
  • 资产收购交易趋势:各技术种类 (2016～2024年)
  • 资产收购交易趋势:最活跃的企业的情况 (2016～2024年)
• 签订资产收购的联盟交易的理由
  • 事业资产
  • 产品资产
  • 特许权资产
  • 技术资产
• 资产收购交易的未来性

第3章 资产收购交易结构:概要

• 简介
• 资产收购契约结构

第4章 资产收购的主要的交易

• 简介
• 前几名的资产收购交易 (以金额为准)

第5章 资产收购交易:最活跃的交易缔结25企业

• 简介
• 资产收购交易:最活跃的交易缔结25企业

第6章 资产收购交易:契约的明细

• 简介
• 资产收购契约 (2016～2024年)
• 交易明细
• 交易明细:资产收购的交易缔结，企业名 (A～Z)
• 交易明细:资产收购的交易缔结，各治疗领域
• 交易明细:资产收购的交易缔结，各技术种类

关于Wildwood Ventures

Asset Purchase Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty asset purchase deals.

The report provides access to asset purchase deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

The report focuses on four primary types of asset available for purchase:

• Business assets
• Product assets
• Royalty assets
• Technology assets
• Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.
• This report contains a comprehensive listing of asset purchase deals announced since 2016 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual asset purchase contract documents as submitted to the Securities Exchange Commission by companies and their partners.
• The initial chapters of this report provide an orientation of asset purchase dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in asset purchase as well as a discussion on the merits of the type of deal.
• Chapter 3 provides an overview of the structure of asset purchase deals.
• Chapter 4 provides a review of the leading asset purchase deals since 2016. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.
• Chapter 5 provides a comprehensive listing of the top 25 most active asset purchase dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.
• Chapter 6 provides a comprehensive and detailed review of asset purchase deals organized by company A-Z, therapy, technology and industry type signed and announced since 2016 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the asset purchase deal.
• The deal directory includes a comprehensive listing of all asset purchase deals announced since 2016. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.
• The report also includes numerous table and figures that illustrate the trends and activities in asset purchase dealmaking since 2016.
• In conclusion, this report provides everything a prospective dealmaker needs to know about asset purchase alliances.

Key benefits

Asset Purchase Deals in Pharmaceuticals and Biotechnology provides the reader with the following key benefits:

• Understand deal trends since 2016
• Browse asset purchase deals
• Benchmark analysis - identify market value of transactions
• Financials - headline, upfront, milestone, royalty rates
• Directory of deals by company A-Z, therapy focus and technology type
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Access contract documents - insights into deal structures
• Due diligence - assess suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Report scope

• Asset Purchase Deals in Pharmaceuticals and Biotechnology is intended to provide the reader with an in-depth understanding of the asset purchase trends and structure of deals entered into by leading biopharma companies worldwide.

Asset Purchase Deals in Pharmaceuticals and Biotechnology includes:

• Trends in asset purchase dealmaking in the biopharma industry
• Overview of asset purchase deal structure
• Directory of asset purchase deal records covering pharmaceutical and biotechnology
• The leading asset purchase deals by value
• Most active asset purchase dealmakers
• The leading asset purchase partnering resources

In Asset Purchase Deals in Pharmaceuticals and Biotechnology, the available deals are listed by:

• Company A-Z
• Headline value
• Therapeutic area
• Technology type
• Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.
• Asset Purchase Deals in Pharmaceuticals and Biotechnology provides comprehensive access to available records for asset purchase deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

• What are the rights granted or optioned?
• What rights are granted by the agreement?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are intellectual property rights handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in asset purchase dealmaking

• 2.1. Introduction
• 2.2. Types of assets purchased
• 2.3. Trends in asset purchase deals since 2016
  • 2.3.1. Asset purchase dealmaking by year, 2016-2024
  • 2.3.2. Asset purchase dealmaking by phase of development, 2016-2024
  • 2.3.3. Asset purchase dealmaking by industry sector, 2016-2024
  • 2.3.4. Asset purchase dealmaking by therapy area, 2016-2024
  • 2.3.5. Asset purchase dealmaking by technology type, 2016-2024
  • 2.3.6. Asset purchase dealmaking by most active company, 2016-2024
• 2.4. Reasons for entering into asset purchase partnering deals
  • 2.4.1. Business assets
  • 2.4.2. Product assets
  • 2.4.3. Royalty assets
  • 2.4.4. Technology assets
• 2.5. The future of asset purchase deals

Chapter 3 - Overview of asset purchase deal structure

• 3.1. Introduction
• 3.2. Asset purchase agreement structure

Chapter 4 - Leading asset purchase deals

• 4.1. Introduction
• 4.2. Top asset purchase deals by value

Chapter 5 - Top 25 most active asset purchase dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active asset purchase dealmakers

Chapter 6 - Asset purchase deals including contracts directory

• 6.1. Introduction
• 6.2. Asset purchase deals with contracts 2016-2024
• Deal directory
• Deal directory - Asset purchase dealmaking by companies A-Z
• Deal directory - Asset purchase dealmaking by therapy area
• Deal directory - Asset purchase dealmaking by technology type

About Wildwood Ventures

• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of assets purchased
• Figure 2: Trends in asset purchase deal announcements, 2016-2024
• Figure 3: Asset purchase deals signed at each phase of development, 2016-2024
• Figure 4: Asset purchase deals by industry sector, 2016-2024
• Figure 5: Asset purchase deals by therapy area, 2016-2024
• Figure 6: Asset purchase deals by technology type, 2016-2024
• Figure 7: Top 25 most active asset purchase dealmakers, 2016-2024
• Figure 8: Top asset purchase deals by value, 2016-2024
• Figure 9: Most active asset purchase dealmakers, 2016-2024